Open AccessEfficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
Author(s) -
Mohamed M ElSeirafi,
Hasan Msn Hasan,
Kannan Sridharan,
Alaa Zamoori,
Sana Alkhawaja,
Sheikh Abdul Azeez Pasha
Publication year - 2020
Publication title -
respiratory medicine case reports
Language(s) - English
Resource type - Journals
ISSN - 2213-0071
DOI - 10.1016/j.rmcr.2020.101139
Subject(s) - tocilizumab , medicine , critically ill , covid-19 , intensive care medicine , virology , rheumatoid arthritis , outbreak , infectious disease (medical specialty) , disease
Tocilizumab has been recognized as one of the few existing biologic useful for combating COVID-19 infections especially in critically ill patient. We had experience in treating five critically ill patients with severe lung injury who were COVID-19 positive with tocilizumab. In the present case series, we have attempted to summarize their clinical profile, changes in laboratory biomarkers and outcomes.